• 1. Establishing plasmon contribution to chemical reactions: alkoxyamines as a thermal probe?
  Olga Guselnikova,Gérard Audran,Jean-Patrick Joly,Andrii Trelin,Evgeny V. Tretyakov,Vaclav Svorcik,Oleksiy Lyutakov,Sylvain R. A. Marque Chem. Sci., 2021,12, 4154-4161
• 2. Excellent lithium ion storage property of porous MnCo2O4 nanorods?
  Peiyuan Zeng,Xiaoxiao Wang,Ming Ye,Qiuyang Ma,Jianwen Li,Wanwan Wang,Baoyou Geng,Zhen Fang RSC Adv., 2016,6, 23074-23084
• 3. Fe(ii)-Assisted one-pot synthesis of ultra-small core–shell Au–Pt nanoparticles as superior catalysts towards the HER and ORR?
  Yi Cao,Yujiao Xiahou,Lixiang Xing,Xiang Zhang,Hong Li,ChenShou Wu,Haibing Xia Nanoscale, 2020,12, 20456-20466
• 4. EWOD-driven droplet microfluidic device integrated with optoelectronic tweezers as an automated platform for cellular isolation and analysis?
  Gaurav J. Shah,Eric P.-Y. Chiou,Ming C. Wu,Chang-Jin “CJ” Kim Lab Chip, 2009,9, 1732-1739
• 5. Embedding cyclic nitrone in mesoporous silica particles for EPR spin trapping of superoxide and other radicals?
  Eric Besson,Stéphane Gastaldi,Emily Bloch,Selma Aslan,Hakim Karoui,Olivier Ouari,Micael Hardy Analyst, 2019,144, 4194-4203

Recent Advances in the Study of Nonadecanoic Acid, 19-hydroxy- (CAS: 22438-61-5): Implications for Chemical Biology and Pharmaceutical Research

Nonadecanoic acid, 19-hydroxy- (CAS: 22438-61-5) is a hydroxylated long-chain fatty acid that has garnered increasing attention in the fields of chemical biology and pharmaceutical research. This compound, characterized by its 19-carbon backbone with a hydroxyl group at the terminal position, exhibits unique physicochemical properties that make it a promising candidate for various biomedical applications. Recent studies have explored its potential roles in lipid metabolism, cell signaling, and as a precursor for the synthesis of bioactive molecules.

A 2023 study published in the Journal of Lipid Research investigated the enzymatic pathways involved in the biosynthesis of 19-hydroxy-nonadecanoic acid in mammalian systems. The research team employed advanced mass spectrometry techniques to trace the metabolic fate of this compound, revealing its incorporation into complex lipid species in hepatic tissues. These findings suggest potential regulatory functions in lipid homeostasis, with implications for metabolic disorder therapeutics.

In pharmaceutical development, Nonadecanoic acid, 19-hydroxy- has shown promise as a structural motif for drug design. A recent patent application (WO2023051234) describes its use as a building block for novel anti-inflammatory agents. The hydroxyl group at the C19 position provides a strategic handle for chemical modification, enabling the creation of derivatives with enhanced bioavailability and target specificity. Molecular docking studies indicate that these derivatives can effectively modulate PPARγ receptors, offering potential applications in diabetes and cardiovascular disease treatment.

The compound's surfactant properties have also been explored in drug delivery systems. Research published in Colloids and Surfaces B: Biointerfaces (2024) demonstrated that 19-hydroxy-nonadecanoic acid can form stable nanoemulsions with improved drug loading capacity compared to conventional fatty acids. This characteristic, attributed to its amphiphilic nature, makes it particularly valuable for formulating poorly water-soluble therapeutics.

Analytical chemistry advancements have facilitated more precise characterization of 22438-61-5. A recent methodological breakthrough in Analytical Chemistry (2024) described a novel chiral separation technique that can resolve the enantiomers of 19-hydroxy-nonadecanoic acid, addressing previous challenges in stereochemical analysis of hydroxylated fatty acids. This development is crucial for understanding the compound's biological activity, as different enantiomers may exhibit distinct pharmacological properties.

Ongoing clinical investigations are exploring the diagnostic potential of 19-hydroxy-nonadecanoic acid as a biomarker. Preliminary data from a multicenter study suggest altered levels of this fatty acid derivative in patients with non-alcoholic fatty liver disease (NAFLD), indicating its potential utility in disease stratification and monitoring therapeutic response. These findings were recently presented at the 2024 International Conference on Liver Disease.

Future research directions for Nonadecanoic acid, 19-hydroxy- include exploring its role in cellular signaling pathways and expanding its applications in medicinal chemistry. The compound's unique structure positions it as a versatile scaffold for developing new therapeutic agents targeting metabolic and inflammatory disorders. As analytical techniques continue to advance, deeper insights into its biological functions and therapeutic potential are expected to emerge in the coming years.

• 68002-88-0(Fatty acids, C16-22)
• 64118-43-0(Undecanoic-2,2-d2 Acid)
• 64118-39-4(Dodecanoic-2,2-d2 Acid)
• 64118-36-1(Octanoic-2,2-d2 acid)
• 64118-37-2(Pentanoic-2,2-d2 Acid)
• 68424-37-3(Fatty acids, C14-22)
• 67762-36-1(Fattyacids, C6-12)
• 646-30-0(Nonadecanoic acid)
• 6250-70-0(Nonadecanedioic acid)
• 68937-75-7(Fatty acids, C8-10)